Jerh Collins is the Chief Technical Operations and Quality Officer at Moderna, a leading biotechnology company. With nearly 30 years of experience at Novartis, Collins has a robust background in pharmaceutical production and manufacturing. Since joining Moderna in October 2022, he has been instrumental in overseeing the company's technical development and quality programs.
Who is the CTO of Moderna?
Dr. Jerh Collins, Ph.D., brings a wealth of experience to his role as Chief Technical Operations and Quality Officer at Moderna. Before joining Moderna in October 2022, Collins spent nearly three decades at Novartis, where he held various senior positions, including Head of Global Chemical Operations and Anti-Infectives. His extensive background in pharmaceutical production and manufacturing has equipped him with the expertise needed to oversee Moderna's technical development and quality programs, ensuring the company maintains its high standards in preclinical, clinical, and commercial supplies.
Work History
Jerh Collins's work history includes an impressive array of positions at various esteemed institutions. Here is a summary of his previous roles:
Education History
Jerh Collins's educational journey is marked by a strong foundation in chemistry and business. He earned his BSc in Chemistry from University College Cork, where he later completed a Ph.D. in Organic Chemistry. Following his doctoral studies, Collins pursued a Post.Doc in Cancer Research at Arizona State University. To further enhance his expertise, he attended Harvard Business School's Business Finance Program, equipping him with essential skills in business finance and management. This diverse educational background has provided Collins with a robust platform to excel in his various professional roles.
When did Jerh Collins join Moderna?
Joining Moderna in October 2022, Jerh Collins brought with him a wealth of experience from his nearly 30-year tenure at Novartis. He assumed the role of Chief Technical Operations and Quality Officer on January 1, 2023. As of now, Collins has been with Moderna for almost a year, contributing significantly to the company's technical development and quality programs.
His extensive background in pharmaceutical production and manufacturing has been instrumental in maintaining Moderna's high standards in preclinical, clinical, and commercial supplies.